KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Vertex Pharmaceuticals (VRTX) Return on Capital Employed: 2010-2025

Historic Return on Capital Employed for Vertex Pharmaceuticals (VRTX) over the last 15 years, with Sep 2025 value amounting to 0.20%.

  • Vertex Pharmaceuticals' Return on Capital Employed rose 22.00% to 0.20% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.20%, marking a year-over-year increase of 22.00%. This contributed to the annual value of -0.01% for FY2024, which is 24.00% down from last year.
  • Vertex Pharmaceuticals' Return on Capital Employed amounted to 0.20% in Q3 2025, which was down 1.55% from 0.20% recorded in Q2 2025.
  • Vertex Pharmaceuticals' Return on Capital Employed's 5-year high stood at 0.33% during Q2 2022, with a 5-year trough of -0.04% in Q1 2025.
  • For the 3-year period, Vertex Pharmaceuticals' Return on Capital Employed averaged around 0.13%, with its median value being 0.20% (2025).
  • Its Return on Capital Employed has fluctuated over the past 5 years, first declined by 26bps in 2024, then increased by 22bps in 2025.
  • Over the past 5 years, Vertex Pharmaceuticals' Return on Capital Employed (Quarterly) stood at 0.26% in 2021, then increased by 4bps to 0.29% in 2022, then declined by 9bps to 0.21% in 2023, then fell by 22bps to -0.01% in 2024, then rose by 22bps to 0.20% in 2025.
  • Its last three reported values are 0.20% in Q3 2025, 0.20% for Q2 2025, and -0.04% during Q1 2025.